| 000 | 01424 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516215650.0 | ||
| 264 | 0 | _c20150409 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1521-4184 | ||
| 024 | 7 |
_a10.1002/ardp.201400116 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCong, Lin | |
| 245 | 0 | 0 |
_aTargeting the TGF-β receptor with kinase inhibitors for scleroderma therapy. _h[electronic resource] |
| 260 |
_bArchiv der Pharmazie _cSep 2014 |
||
| 300 |
_a609-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xchemistry |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aMolecular Dynamics Simulation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMorpholines _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aPyrazoles _xchemistry |
| 650 | 0 | 4 |
_aQuinolines _xchemistry |
| 650 | 0 | 4 |
_aQuinoxalines _xchemistry |
| 650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
| 700 | 1 | _aXia, Zhi-Kuan | |
| 700 | 1 | _aYang, Rong-Ya | |
| 773 | 0 |
_tArchiv der Pharmazie _gvol. 347 _gno. 9 _gp. 609-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ardp.201400116 _zAvailable from publisher's website |
| 999 |
_c23907444 _d23907444 |
||